Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 30559126

Apatinib for Advanced Osteosarcoma after Failure of Standard Multimodal Therapy: An Open Label Phase II Clinical Trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Oncologist
Publication date
2019 Jul
First author
Xie L

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Xie L
      type
      Author
    2. name
      Xu J
      type
      Author
    3. name
      Sun X
      type
      Author
    4. name
      Tang X
      type
      Author
    5. name
      Yan T
      type
      Author
    6. name
      Yang R
      type
      Author
    7. name
      Guo W
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Xie L
      type
      Author
    2. name
      Xu J
      type
      Author
    3. name
      Sun X
      type
      Author
    4. name
      Tang X
      type
      Author
    5. name
      Yan T
      type
      Author
    6. name
      Yang R
      type
      Author
    7. name
      Guo W
      type
      Author
    bibliography ids
    1. nci-bib-aa02375aa4454ee44d364589
    book metadata
    content sha256
    14a09df791162051c4be0bf941103de5dbbab18a079efede449806e100a8f16a
    document type
    citation
    dois
    1. 10.1634/theoncologist.2018-0542
    electronic publication date
    display
    2018 Dec 17
    precision
    day
    year
    2018
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:30559126
    immutable id
    pubmed:30559126@14a09df791162051c4be0bf941103de5dbbab18a079efede449806e100a8f16a
    journal
    abbreviation
    Oncologist
    issn electronic
    1549-490X
    issn print
    1083-7159
    issue
    7
    name
    The oncologist
    nlm unique id
    9607837
    pages
    e542-e550
    volume
    24
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      30559126
      provenance
      batch id
      438b2803888025c6cf56
      provider
      NCBI PubMed ESummary
      record sha256
      d84b2e9f3631bfa6fcd366cbeb0e1c6ba71d6675efb808fcd5a1294d19b9d275
      response sha256
      0adf5ff07d3aa03a45feef5e4b7998e2ddea370eb9d1c6aa9134c5fd329767e6
      retrieved at
      2026-09-09T23:47:36.359220+00:00
      publication date
      display
      2019 Jul
      precision
      month
      year
      2019
      publication types
      1. Clinical Trial, Phase II
      2. Journal Article
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/30559126/
      title
      Apatinib for Advanced Osteosarcoma after Failure of Standard Multimodal Therapy: An Open Label Phase II Clinical Trial.

      Preserved source evidence · Not medical advice